102 However, various groups are advocating for that incorporation of novel markers, like a advanced karyotype55 or epigenetic subsets, 27,28 into clinical observe. Every one of these novel prognostic and/or predictive products will have to be validated in cohorts of clients treated with focused brokers.Kendati begitu, Meutya menyebut, sejumlah peru